The cost and cost trajectory of whole-genome analysis guiding treatment of patients with advanced cancers-Reference-Cited by-同舟云学术

The cost and cost trajectory of whole-genome analysis guiding treatment of patients with advanced cancers

Published:2017-03-12 Issue:3 Volume:5 Page:251-260
ISSN:2324-9269
Container-title:Molecular Genetics & Genomic Medicine
language:en
Short-container-title:Mol Genet Genomic Med

Author:

Weymann Deirdre¹^ORCID,Laskin Janessa²,Roscoe Robyn³,Schrader Kasmintan A.⁴⁵,Chia Stephen²⁶,Yip Stephen⁷⁸,Cheung Winson Y.²⁶,Gelmon Karen A.²⁶,Karsan Aly²³⁷,Renouf Daniel J.²⁶,Marra Marco³⁴,Regier Dean A.¹⁹

Affiliation:

1. Canadian Centre for Applied Research in Cancer Control (ARCC); Cancer Control Research; BC Cancer Agency; Vancouver British Columbia Canada

2. Division of Medical Oncology; BC Cancer Agency; Vancouver British Columbia Canada

3. Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency; Vancouver British Columbia Canada

4. Department of Medical Genetics; Faculty of Medicine; University of British Columbia; Vancouver British Columbia Canada

5. Department of Molecular Oncology; BC Cancer Agency; Vancouver British Columbia Canada

6. Department of Medicine; Faculty of Medicine; University of British Columbia; Vancouver British Columbia Canada

7. Department of Pathology & Laboratory Medicine; Faculty of Medicine; University of British Columbia; Vancouver British Columbia Canada

8. Department of Pathology; BC Cancer Agency; Vancouver British Columbia Canada

9. School of Population and Public Health; Faculty of Medicine; University of British Columbia; Vancouver British Columbia Canada

Funder

BC Personalized OncoGenomics Program

Canadian Centre for Applied Research in Cancer Control

Canadian Cancer Society Research Institute

Publisher

Wiley

Subject

Genetics (clinical),Genetics,Molecular Biology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mgg3.281/fullpdf

Reference37 articles.

1. Next-generation sequencing in NSCLC and melanoma patients: a cost and budget impact analysis;Amerongen;Ecancermedicalscience,2016

2. Analysis of cost data in randomized trials: an application of the non-parametric bootstrap;Barber;Stat. Med.,2000

3. Genome sequence data: management, storage, and visualization;Batley;Biotechniques,2009

4. BC Cancer Statistics - Facts and Figures 2016 http://www.bccancer.bc.ca/health-info/disease-system-statistics/bc-cancer-statistics/facts-and-figures

5. CADTH 2014 Next generation DNA sequencing: a review of the cost effectiveness and guidelines.

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Next-generation sequencing in pharmacogenomics – fit for clinical decision support?;Expert Review of Clinical Pharmacology;2024-01-22

2. Coût des technologies de séquençage haut débit (NGS) : revue de la littérature et enseignements;Bulletin du Cancer;2023-10

3. Microcosting diagnostic genomic sequencing: A systematic review;Genetics in Medicine;2023-06

4. Circulating tumor DNA: toward evolving the clinical paradigm of pancreatic ductal adenocarcinoma;Therapeutic Advances in Medical Oncology;2023-01

5. Towards clinical implementation of circulating tumor DNA in metastatic prostate cancer: Opportunities for integration and pitfalls to interpretation;Frontiers in Oncology;2022-11-10